Publications by authors named "Geoffrey Cox"

8Publications

Preoperative biomarker evaluation for the prediction of cardiovascular events after major vascular surgery.

J Vasc Surg 2019 11;70(5):1564-1575

Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Victoria, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2019.02.041DOI Listing
November 2019

Quinke's triad: haemobilia secondary to hepatic artery aneurysm.

ANZ J Surg 2019 05 12;89(5):E214-E215. Epub 2017 Nov 12.

Department of Vascular Surgery, Alfred Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ans.14250DOI Listing
May 2019

The effect of spontaneous curvature on a two-phase vesicle.

Nonlinearity 2015 Mar;28(3):773-793

University of California, Irvine, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/0951-7715/28/3/773DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472470PMC
March 2015

Fresh arterial homograft for bypass in critical limb ischaemia with infection.

BMJ Case Rep 2015 May 20;2015. Epub 2015 May 20.

Alfred Hospital, Prahran, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2015-210218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442165PMC
May 2015

Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2.

Bioorg Med Chem Lett 2006 Mar 27;16(6):1696-701. Epub 2005 Dec 27.

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2005.12.006DOI Listing
March 2006

Heteroaryl-O-glucosides as novel sodium glucose co-transporter 2 inhibitors. Part 1.

Bioorg Med Chem Lett 2005 Dec 28;15(23):5202-6. Epub 2005 Sep 28.

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0960894X0501098
Publisher Site
http://dx.doi.org/10.1016/j.bmcl.2005.08.067DOI Listing
December 2005

Glycosylated dihydrochalcones as potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitors.

Bioorg Med Chem Lett 2004 Oct;14(20):5121-5

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Rt. 202, PO Box 300, Raritan, NJ 08869, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2004.07.082DOI Listing
October 2004